January 15, 2026
Universal Cancer-Fighting Cells: A New Era in Leukemia Treatment
Base-edited CAR-T cells from healthy donors achieve 64% remission in patients with relapsed T-cell leukemia, offering hope for faster, more accessible treatment.
Read Article →
